Advisory Board Member

Location: Remote
Engagement: 1–2 hours per month
Compensation: Sweat Equity

About Mercurial AI

Mercurial Artificial Intelligence is developing oncology focused AI tools designed to make cancer care more understandable, efficient, and accessible for both clinicians and patients.

The company’s platform includes two core products. OncoPilot is an AI clinical assistant designed to reduce documentation burden and support oncology workflows. Sona is a 24/7 patient companion that delivers personalized and reliable cancer guidance outside the hospital setting.

Oncology practices face increasing administrative pressure, physician burnout, growing after hours workload, and fragmented patient communication. At the same time, much of the cancer journey happens outside clinical settings, where patients often struggle to find clear and trustworthy guidance.

Mercurial AI addresses these challenges by providing real time clinical support for physicians alongside continuous patient navigation. This approach reduces operational costs while improving both care delivery and patient experience.

As deployments expand across cancer centers and specialty practices, the company is forming an Advisory Board to guide enterprise adoption, product strategy, and clinical integration.

Advisory Board Summary

Mercurial AI is seeking experienced leaders across oncology, clinical operations, healthcare AI, digital health commercialization, and enterprise healthcare strategy to join its Advisory Board.

Advisors will help shape oncology focused go to market strategy, clinical workflow integration and adoption, partnerships with cancer centers and specialty networks, evidence frameworks that demonstrate operational and clinical return on investment, and long term positioning in AI enabled oncology care.

This role is ideal for leaders who understand how high trust clinical technology scales within complex healthcare systems, particularly in areas where physician burnout, patient engagement, and workflow efficiency intersect.

Key Responsibilities

Market and Commercial Strategy

Advise on oncology focused enterprise go to market strategy.

Support pricing, packaging, and adoption models.

Guide pilot programs and center of excellence partnerships.

Clinical Workflow and Product Alignment

Evaluate physician documentation workflows and operational impact.

Advise on real world oncology workflow integration.

Help align patient navigation tools with established care pathways.

Partnerships and Ecosystem Development

Enable introductions to cancer centers, oncology groups, and healthcare systems.

Provide guidance on strategic partnerships with digital health platforms.

Organizational and Strategic Growth

Provide scaling guidance and roadmap recommendations.

Strengthen the company’s enterprise narrative and clinical credibility.

Ideal Candidates

Mercurial AI is seeking leaders with backgrounds such as oncology physicians or cancer center executives, clinical operations leaders in specialty care, healthcare AI or digital health executives, enterprise healthcare SaaS commercialization leaders, and patient engagement or care navigation strategists.

Preferred Experience

Ten or more years of experience in oncology, specialty healthcare operations, or healthcare technology.

Experience scaling clinician workflow tools.

Familiarity with patient engagement platforms.

A demonstrated track record of enterprise healthcare adoption.

Why Join Mercurial AI

Help address oncology burnout by reducing documentation strain and after hours workload.

Support transformation of patient navigation by delivering reliable cancer guidance outside clinic hours.

Contribute to clinically grounded AI tools designed specifically for oncology workflows.

Participate in building enterprise scalable systems designed to integrate seamlessly with existing healthcare infrastructure.

Create meaningful impact by improving both physician wellbeing and patient understanding during the cancer journey.

Compensation and Participation

Advisory participation is compensated through equity aligned with advisor contribution.

Advisors will play a direct role in shaping the future of oncology focused AI tools.

An optional investment opportunity may also be available. Advisors may participate in early stage investment rounds, typically between $25,000 and $50,000, and may be able to invest through retirement vehicles such as an IRA or 401K.

Equal Opportunity Commitment

Mercurial AI is committed to building a diverse Advisory Board that reflects the multidisciplinary nature of modern oncology care and healthcare innovation.

‍